-The Telegraph Even as it is busy trying to resolve other people's conflicts in so many parts of the world, the United Nations has recently created a conflict of its own. It began innocuously enough. The organization has always tried to get consensus around matters on which it is often very difficult to arrive at such consensus. The usual strategy to achieve this is to sufficiently water down the language in its...
More »SEARCH RESULT
When the burden falls on the poor-Arun Kumar
-The Hindu Policies being pursued in India are based on the growth-at-any-cost model. The poor and the enviroment suffer while the corporates and organised sectors reap the benefits The Aam Aadmi Party, having won the trust vote, is now in the saddle in Delhi. By announcing several measures to benefit Delhiites, it had already impacted the political discourse in the nation. The established political parties are trying to follow suit. Why did...
More »Toilet truths flush school dreams-Chhandosree
-The Telegraph Ranchi: The lid is off a basic reason why generations of girls drop out of school, never discovering their potential. Schools, state-run or otherwise, may have a toilet, but if existing loos lack basics such as privacy or water, girls prefer to stay at home. Reason - they feel too unsafe and ashamed to answer nature's call or take care of personal hygiene during menstruation. A detailed research on life skills...
More »Industry tops anti-graft rankings
-The Telegraph Mumbai: Just when India Inc is battling a welter of accusations about crony capitalism, Transparency International has put out a report that will buttress its argument that the CBI-inspired witch hunt to name and shame some of the best-known business barons in the country is "preposterous and unwarranted". The report says Indian companies have the greatest commitment to fight corruption and the best internal systems in place to do so...
More »EU fines Ranbaxy, others for blocking cheaper drugs
-Reuters BRUSSELS: Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant medicine to the market. The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. The EU action came two days...
More »